EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Safety and performance of the next generation EnligHTN™ renal denervation system in patients with drug-resistant, uncontrolled hypertension: The EnligHTN III first-in-human multicentre study

Stephen G. Worthley, Gerard T. Wilkins, Mark W. Webster, Joseph K. Montarello, Paul R. Antonis, Robert J. Whitbourn, Roderic J. Warren

Clinical Trials and Regulatory Science in Cardiology · 2015

DOI: 10.1016/j.ctrsc.2015.08.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Trials and Regulatory Science in Cardiology, 2015. Verfasst von Stephen G. Worthley und 6 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: St. Jude Medical, Inc..

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • St. Jude Medical, Inc.

Zitieren

APA

Worthley, S. G., Wilkins, G. T., Webster, M. W., Montarello, J. K., Antonis, P. R., Whitbourn, R. J., & Warren, R. J. (2015). Safety and performance of the next generation EnligHTN™ renal denervation system in patients with drug-resistant, uncontrolled hypertension: The EnligHTN III first-in-human multicentre study. Clinical Trials and Regulatory Science in Cardiology. https://doi.org/10.1016/j.ctrsc.2015.08.007

Vancouver

Worthley SG, Wilkins GT, Webster MW, Montarello JK, Antonis PR, Whitbourn RJ, et al. Safety and performance of the next generation EnligHTN™ renal denervation system in patients with drug-resistant, uncontrolled hypertension: The EnligHTN III first-in-human multicentre study. Clinical Trials and Regulatory Science in Cardiology. 2015. doi:10.1016/j.ctrsc.2015.08.007

BibTeX
@article{Worthley2015,
  author = {Worthley, Stephen G. and Wilkins, Gerard T. and Webster, Mark W. and Montarello, Joseph K. and Antonis, Paul R. and Whitbourn, Robert J. and Warren, Roderic J.},
  title = {Safety and performance of the next generation EnligHTN™ renal denervation system in patients with drug-resistant, uncontrolled hypertension: The EnligHTN III first-in-human multicentre study},
  journal = {Clinical Trials and Regulatory Science in Cardiology},
  year = {2015},
  doi = {10.1016/j.ctrsc.2015.08.007}
}
Kostenlos starten →